报告的剂量与阿姆洛迪平暴露的结果之间的关系:25年后期的中毒中心审查
Colleen P Cowdery1, Courtney Temple1
1Department of Emergency Medicine, Oregon Health & Science University, Portland, OR, USA.
Clinical toxicology (Philadelphia, Pa.)
|September 4, 2025
概括
高剂量的安洛迪平 (通道阻断剂) 中毒可能导致严重的休克. 摄入400毫克或更多增加耐火性休克的风险,需要先进的治疗,如静脉动脉外膜氧化.
科学领域:
- 毒理学
- 心脏病学
- 临床医学
背景情况:
- 阿姆洛迪平是一种二皮林通道阻断剂,越来越多地与致命中毒有关.
- 延迟的度可以掩盖初始中毒的严重程度.
- 对于预测临床结果而言,按剂量分层对阿姆洛迪平的暴露至关重要.
研究的目的:
- 与临床结果相关报道的阿姆洛迪平摄入剂量.
- 确定阿姆洛迪平严重毒性的值.
- 根据摄入剂量评估是否需要先进干预措施.
主要方法:
- 对于25年来俄勒冈毒品中心的记录,
- 包括标准:阿姆洛迪平暴露,报告的剂量,没有心脏活性同时摄入,接受了血管活性/ 异位药物治疗.
- 对血管压缩剂使用,静脉外体膜氧化 (VA- ECMO) 和死亡率的剂量反应关系的分析.
主要成果:
- 摄入≤250mg的20例患者最少需要血管抑制剂,1例VA- ECMO,没有死亡.
- 摄入401至1000毫克的14例病例显示,86%需要≥4种血管抑制剂,43%的VA- ECMO,29%的死亡率.
- 七例701至1000毫克的摄入都需要4个血管压缩剂;57%接受VA- ECMO并存活.
结论:
- 阿姆洛迪平的毒性可能导致阻燃性血管.
- 摄入剂量与血管压缩剂需求,VA- ECMO使用和死亡率相关.
- 摄入量≥400mg需要及早转移至高级护理,包括VA-ECMO,剂量作为风险分层工具.
相关概念视频
01:14Time Course of Drug Effect
2.2K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.2K
01:19Pharmacovigilance
981
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
981
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
01:15Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
01:03Dose-Response Relationship: Overview
3.6K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.6K
01:22Dose-Response Relationship: Potency and Efficacy
5.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.1K